Thyroid Incidentalomas on 18F-Fluorodeoxyglucose Positron Emission Tomography–Computed Tomography: A Tertiary Care Hospital Experience in South India
Justin Benjamin, Julie Hephzibah, David Mathew, Nylla Shanthly, Shawn S Thomas, Elanthenral Sigamani, Santosh Raj, Regi Oommen, Reetu A John, Paul Mazhuvanchary Jacob
Citation Information :
Benjamin J, Hephzibah J, Mathew D, Shanthly N, Thomas SS, Sigamani E, Raj S, Oommen R, John RA, Jacob PM. Thyroid Incidentalomas on 18F-Fluorodeoxyglucose Positron Emission Tomography–Computed Tomography: A Tertiary Care Hospital Experience in South India. World J Endoc Surg 2024; 16 (2):32-35.
Thyroid incidentalomas on fluorine-18-fluorodeoxyglucose positron emission tomography–computed tomography (18F-FDG-PET-CT): A tertiary care hospital experience in South India.
Aim: To find the prevalence and clinical significance of unexpected focal uptake of 18F-FDG or nodules in the thyroid gland of consecutive PET-CT studies. To find the maximum standardized uptake value (SUVmax) of benign and malignant thyroid incidentalomas in FDG-avid lesions.
Materials and methods: A total of 2,699 18F-FDG-PET-CT studies from January to December 2018 were reviewed. Studies with incidental focal 18F-FDG uptake with SUVmax, sonography, cytology, and histopathological results were compiled and analyzed. FDG nonavid thyroid nodules on CT were also studied.
Results: In 312/2,699 patients with thyroid nodules, 18F-FDG uptake was identified in 139 (5%)—focal (76) and diffuse (63). In the cases with focal uptake, 42 were further evaluated, of which ultrasound (USG) showed thyroid imaging reporting and data system (TIRADS) 2/3 in 21 cases, TIRADS 4/5 in 20 cases, and 1 patient underwent surgery. Final histopathological examination (HPE) was suggestive of papillary thyroid carcinoma. The mean SUVmax in malignant nodules (20.20) was significantly higher (p < 0.03) than benign nodules (6.12), but there was considerable overlap (benign: 3.75–10.25; malignant: 3.34–48.32) between them. Among FDG nonavid nodules (173), only 24 were followed up with sonography [7/24 (29.16%) had TIRADS 4/5 lesions]. Only 2/173 were diagnosed with malignancy.
Conclusion: Thyroid incidentalomas, though infrequent, showing 18F-FDG uptake should be evaluated with sonography followed by biopsy/fine needle aspiration (FNA) if required, to rule out malignancy. The SUVmax value was significantly lower in benign incidentalomas compared to malignant nodules; however, there was no clinically useful SUVmax cutoff value to determine malignancy due to considerable overlap between them.
Clinical significance: Thyroid carcinomas detected by 18F-FDG-PET-CT are more aggressive than those detected by other imaging modalities. From our study, we found that there is a prevalence of at least 5% of thyroid incidentalomas. Therefore, understanding the importance of further steps in evaluation is needed to avoid unnecessary investigations and also to avoid missing the possibility of detecting malignancy. This study also stated that having a cutoff value for SUVmax is ambiguous in differentiating between benign and malignant nodules.
Poeppel TD, Krause BJ, Heusner TA, et al. PET/CT for the staging and follow-up of patients with malignancies. Eur J Radiol 2009;70(3):382. DOI: 10.1016/j.ejrad.2009.03.051
Bomanji JB, Costa DC, Ell PJ. Clinical role of positron emission tomography in oncology. Lancet Oncol 2001;2(3):157. DOI: 10.1016/s1470-2045(00)00257-6
Chen YK, Ding HJ, Chen KT, et al. Prevalence and risk of cancer of focal thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography for cancer screening in healthy subjects. Anticancer Res 2005;25(2B):1421–1426. PMID: 15865100.
Are C, Hsu JF, Schoder H, et al. FDG-PET detected thyroid incidentalomas: need for further investigation? Ann Surg Oncol 2007;14(1):239. DOI: 10.1245/s10434-006-9181-y
Kim TY, Kim WB, Ryu JS, et al. 18F-fluorodeoxyglucose uptake in thyroid from positron emission tomogram (PET) for evaluation in cancer patients: high prevalence of malignancy in thyroid PET incidentaloma. Laryngoscope 2005;115(6):1074. DOI: 10.1097/01.MLG.0000163098.01398.79
Kang KW, Kim SK, Kang HS, et al. Prevalence and risk of cancer of focal thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography for metastasis evaluation and cancer screening in healthy subjects. J Clin Endocrinol Metab 2003;88(9):4100. DOI: 10.1210/jc.2003-030465
Makis W, Ciarallo A. Thyroid incidentalomas on 18F-FDG PET/CT: clinical significance and controversies. Mol Imaging Radionucl Ther 2017;26(3):93–100. DOI: 10.4274/mirt.94695
Choi JY, Lee KS, Kim HJ, et al. Focal thyroid lesions incidentally identified by integrated 18F-FDG PET/CT: clinical significance and improved characterization. J Nucl Med 2006;47:609–615. PMID: 16595494.
Roddy S, Biggans T, Raofi AK, et al. Prevalence of incidental thyroid malignancy on routine 18F-fluorodeoxyglucose PET-CT in a large teaching hospital. Eur J Hybrid Imaging 2020;4(1):21. DOI: 10.1186/s41824-020-00089-5
Van den Bruel A, Maes A, De Potter T, et al. Clinical relevance of thyroid fluorodeoxyglucose-whole body positron emission tomography incidentaloma. J Clin Endocrinol Metab 2002;87(4):1517. DOI: 10.1210/jcem.87.4.8371
Haber RS, Weiser KR, Pritsker A, et al. GLUT1 glucose transporter expression in benign and malignant thyroid nodules. Thyroid Off J Am Thyroid Assoc 1997;7(3):363. DOI: 10.1089/thy.1997.7.363
Soelberg KK, Bonnema SJ, Brix TH, et al. Risk of malignancy in thyroid incidentalomas detected by 18F-fluorodeoxyglucose positron emission tomography: a systematic review. Thyroid 2012;22(9):918. DOI: 10.1089/thy.2012.0005
Pagano L, Samà MT, Morani F, et al. Thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography with CT (FDG-PET/CT): clinical and pathological relevance. Clin Endocrinol (Oxf) 2011;75(4):528. DOI: 10.1111/j.1365-2265.2011.04107.x
Karantanis D, Bogsrud TV, Wiseman GA, et al. Clinical significance of diffusely increased 18F-FDG uptake in the thyroid gland. J Nucl Med 2007;48(6):896. DOI: 10.2967/jnumed.106.039024
Liu Y. Clinical significance of thyroid uptake on F18-fluorodeoxyglucose positron emission tomography. Ann Nucl Med 2009;23(1):17. DOI: 10.1007/s12149-008-0198-0
Kim BH, Na MA, Kim IJ, et al. Risk stratification and prediction of cancer of focal thyroid fluorodeoxyglucose uptake during cancer evaluation. Ann Nucl Med 2010;24(10):721. DOI: 10.1007/s12149-010-0414-6
Ho TY, Liou MJ, Lin KJ, et al. Prevalence and significance of thyroid uptake detected by 18F-FDG PET. Endocrine 2011;40(2):297. DOI: 10.1007/s12020-011-9470-5
Bertagna F, Treglia G, Piccardo A, et al. Diagnostic and clinical significance of F-18-FDG-PET/CT thyroid incidentalomas. J Clin Endocrinol Metab 2012;97(11):3866. DOI: 10.1210/jc.2012-2390